Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $27 Price Target

TYRA BIOSCIENCES, INC. +2.18%

TYRA BIOSCIENCES, INC.

TYRA

14.98

+2.18%

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ: TYRA) with a Outperform and maintains $27 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via